Davis KL, Kaye JA, Masters ET, Iyer S. Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib. Curr Oncol. 2018 Feb;25(1):e40-9. doi: 10.3747/co.25.3723
Mauskopf JA, French MT. Estimating the value of avoiding morbidity and mortality from foodborne illnesses. Risk Anal. 1991 Dec 1;11(4):619-31.
Mauskopf JA. Projections of cancer risks attributable to future exposure to asbestos. Risk Anal. 1987 Dec 1;7(4):477-86.